The copmany's goal was to offer cheaper prescription drugs to Americans, saving millions of people money. (Photo: Shutterstock)
Six years ago, the Yale-educated Chaiken brothers, Geoffrey and Matthew, had an audacious idea: Upend the $333 billion U.S. prescription drug market by selling medicines online at big discounts and create a health-care startup that could stand alongside the giants of tech. One pitch included a slide that put their ambitions in the same league as Uber and Amazon.
It hasn't worked out that way so far. Their company, Blink Health, has snared more than $165 million in venture capital, including from former Morgan Stanley Chairman John Mack. But the brothers and their startup have been entangled in lawsuits and shadowed by deals that saw industry partners turn from friend to foe, competition from two defecting employees, a threat from Amazon itself and no end of bad blood along the way.
Recommended For You
Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.
Your access to unlimited BenefitsPRO content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2025 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
